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AbstrAct
Ocular neuromyotonia is a rare, albeit 
treatable, ocular motor disorder, characterised 
by recurrent brief episodes of diplopia due 
to tonic extraocular muscle contraction. 
Ephaptic transmission in a chronically 
damaged ocular motor nerve is the possible 
underlying mechanism. It usually improves with 
carbamazepine. A 53-year-old woman presented 
with a 4-month history of recurrent episodes of 
binocular vertical diplopia (up to 40/day), either 
spontaneously or after sustained downward 
gaze. Between episodes she had a mild left 
fourth nerve palsy. Sustained downward gaze 
consistently triggered downward left eye tonic 
deviation, lasting around 1 min. MR scan of the 
brain was normal. She improved on starting 
carbamazepine but developed a rash that 
necessitated stopping the drug. Switching to 
lacosamide controlled her symptoms.
cAse report
A previously healthy 53-year-old woman 
presented with a 4-month history of 
recurrent short episodes of binocular 
vertical diplopia lasting around 1 min, 
occurring up to 40 times per day. On 
examination between episodes, her ocular 
ductions were full and there was no 
ocular misalignment on alternate cover 
testing. However, on Hess test there was 
mild vertical strabismus, that is, hyperde-
viation of the left eye, increasing in right 
and downward gaze (figure 1), consistent 
with a left fourth nerve palsy. Sustained 
downward gaze consistently triggered 
marked left eye hypodeviation lasting 
around 1 min and associated with vertical 
diplopia (online supplementary video 1). 
The remainder of the exam was unremark-
able. MR scan of the brain, serum thyroid 
hormone panel, serum antiacetylcholine 
receptor and antimuscle-specific kinase 
antibody panel, and repetitive nerve stim-
ulation were normal. We diagnosed left 
fourth nerve ocular neuromyotonia, and 
started carbamazepine 200 mg twice a day, 
with complete resolution of her symp-
toms. However, 1 week later, she devel-
oped an adverse cutaneous drug reaction, 
and so we stopped the carbamazepine. 
Subsequent dermatological testing recom-
mended against her using oxcarbazepine, 
eslicarbazepine acetate, phenobarbital or 
phenytoin. As her diplopia recurred, she 
Figure 1 Hess test. There is a limitation of infraduction of the left eye, which worsens in right and 
downgaze (best seen in the left segment) (the nine cardinal positions of gaze in the left segment 
are represented by blue dots (left eye) and yellow dots (right eye), and in the right segment by 
yellow dots (left eye) and red dots (right eye). Note that the left eye field is slightly above the right 
eye field, particularly in right and downgaze, reflecting the presence of vertical strabismus due to 
an underaction of the left superior oblique muscle (ie, left fourth nerve palsy). (In the Hess test, the 
patient moves a spot seen only by one eye in a screen until it appears superimposed on a second spot 
seen by the other eye, in order to measure ocular alignment.)
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was started on lacosamide 100 mg twice a day with a 
prompt and sustained clinical response (online supple-
mentary video 1).
Discussion
Ocular neuromyotonia is a rare yet treatable cause of 
transient diplopia. It is due to a spasm of one or more 
extraocular muscles that may occur spontaneously 
and after holding eccentric gaze.1 It can involve any 
extraocular muscle, including the levator palpebrae 
superioris, and lasts between seconds and 3–4 min.2 It 
most commonly occurs in the setting of cranial irra-
diation, nerve compression of vascular or meningeal 
origin, and autoimmune disorders (eg, myasthenia 
gravis and thyroid eye disease).1 Many cases are 
idiopathic and are frequently accompanied by mild 
paresis of the affected muscle in between episodes,2 
as in this case. The pathophysiology probably relates 
to nerve demyelination and ephaptic transmission, 
although repatterning of central circuits and a mech-
anism similar to that of systemic neuromyotonia (ie, 
calcium channel dysfunction) are alternative causes.2 
As in other ephaptic transmission conditions, volt-
age-gated sodium channel (VGSC) blockers (ie, 
carbamazepine, oxcarbazepine, phenytoin, lamo-
trigine) are recommended, although a few reported 
refractory cases undergo surgical microvascular 
decompression.3 In this case, given the occurrence 
of a carbamazepine-induced cutaneous adverse reac-
tion, we considered lacosamide, given the risk of 
adverse drug reaction with other VGSC blockers, 
its low risk of cross-reactivity, side-effect profile 
and action mechanism. Specifically, both carbamaz-
epine and lacosamide act on the VGSC. However, 
carbamazepine stabilises the channel in the fast-in-
activating phase in a use-dependent fashion, while 
lacosamide stabilises it in the slow-inactivating phase, 
with weak use dependence, thus decreasing VGSC 
availability.4 Furthermore, carbamazepine may also 
act on calcium channels, while lacosamide appears 
to have no effect on those channels.4 Although the 
clinical correlate of these physiological differences is 
elusive, efficacy in this patient was not hampered by 
the differences in mechanism of action.
In conclusion, this case illustrates ocular neuro-
myotonia as a rare cause of transient diplopia, which 
fully responded to lacosamide. Our observation 
expands the therapeutic armamentarium for ocular 
neuromyotonia.
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Video 1 See online for the full video.
Key Points
 ► Ocular neuromyotonia is characterised by tonic spasms 
involving one or more extraocular muscles.
 ► Ocular neuromyotonia should be considered in the 
differential diagnosis of recurrent diplopia, particularly 
when following previous nerve injury.
 ► Patients with suspected ocular neuromyotonia should 
undergo MR scan of the brain to exclude secondary 
causes of ocular neuromyotonia.
 ► Ocular neuromyotonia responds to carbamazepine, 
although other sodium channel blockers, including 
lacosamide, may be effective.
Referee’s comment
We asked Dr Mark Lawden, who refereed this paper, to 
help readers to distinguish between ocular neuromyotonia 
and superior oblique myokymia. Here is his reply
    ____________________________
In ocular neuromyotonia the eye gets temporarily 
stuck after looking in the direction of the affected muscle 
causing sustained diplopia on looking back the primary 
position. This gradually goes off after a minute or two as 
in the video in this paper. The cause may be compression, 
prior irradiation or idiopathic. 
https://www.youtube.com/watch?v=0NAb70xWZjQ 
(accessed 15/02/2018)
In superior oblique myokymia there are repetitive very 
brief torsional movements of the eye causing brief vertical 
diplopia. The cause is probably microvascular compression 
as with trigeminal neuralgia and hemifacial spasm.
https://www.youtube.com/watch?v=HwsJvCOC6_Q 
(accessed 15/02/2018)
You can just about see it in the above video clip (it’s 
very subtle).
group.bmj.com on February 21, 2018 - Published by http://pn.bmj.com/Downloaded from 
3Soares-dos-Reis R, et al. Pract Neurol 2018;0:1–3. doi:10.1136/practneurol-2017-001866
Neurological rarities
reFerences
 1 Lueck CJ. Infranuclear ocular motor disorders. Handb Clin 
Neurol 2011;102:281–318.
 2 Roper-Hall G, Chung SM, Cruz OA. Ocular neuromyotonia: 
differential diagnosis and treatment. Strabismus  
2013;21:131–6.
 3 Strupp M, Dieterich M, Brandt T, et al. Therapy of Vestibular 
Paroxysmia, Superior Oblique Myokymia, and Ocular 
Neuromyotonia. Curr Treat Options Neurol 2016;18:34.
 4 Rogawski MA, Tofighy A, White HS, et al. Current 
understanding of the mechanism of action of the antiepileptic 
drug lacosamide. Epilepsy Res 2015;110:189–205.
group.bmj.com on February 21, 2018 - Published by http://pn.bmj.com/Downloaded from 
Ocular neuromyotonia
Conceição Bento and João Lemos
Ricardo Soares-dos-Reis, Ana Inês Martins, Ana Brás, Anabela Matos,
 published online February 21, 2018Pract Neurol
 http://pn.bmj.com/content/early/2018/02/21/practneurol-2017-001866
Updated information and services can be found at: 
These include:
References
 #ref-list-1
http://pn.bmj.com/content/early/2018/02/21/practneurol-2017-001866
This article cites 4 articles, 0 of which you can access for free at: 
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on February 21, 2018 - Published by http://pn.bmj.com/Downloaded from 
